Airbnb said Monday that it has raised $1 billion in debt and equity from private equity firms Silver Lake and Sixth Street Partners, even as the online rental marketplace has seen its business plummet due to the COVID-19 pandemic.

Terms of the deal were not disclosed. Itunclear how this funding might alter Airbnbpreviously shared plans to go public.

COVID-19, the disease caused by coronavirus, prompted governments throughout the world to issue stay-at-home orders, triggering a wave of cancellations in the travel and hospitality industries. Airbnb emphasized that the funds would support its ongoing work to invest over the long term, a statement aimed at couching this raise as strategic and not a bailout in troubled times.

&While the current environment is clearly a difficult one for the hospitality industry, the desire to travel and have authentic experiences is fundamental and enduring,& Silver Lake co-CEO and managing partner Egon Durban said in a statement. &Airbnbdiverse, global, and resilient business model is particularly well suited to prosper as the world inevitably recovers and we all get back out to experience it.&

Airbnb CEO Brian Chesky acknowledged Monday that while the desire to connect and travel has been reinforced during this time, the &way it manifests will evolve as the world changes.&

Airbnb is betting how and where people work will evolve. As a result, the company said it will direct its attention and new funds toward three core products: hosts, long-term stays and Airbnb experiences.

Last month, Airbnb said it would direct $250 million to help hosts who have been impacted by COVID-19. The funds will be used to pay a host 25% of what they would normally receive through their cancellation policy if a guest cancels areservation due to COVID-19 between March 14 and May 31. Airbnb said this policy applies retroactively to all cancellations during that period.

The move was an attempt by Airbnb to make amends to its hosts who complained that the companypolicywould allow guests to cancel reservations and receive a full refund. That policy, which is still active, lets guests who booked reservations on or before March 14 that begin anytime on or before May 31 to cancel and receive a standard refund or travel credit.

While a number of startups have been hard hit by efforts to curb the spread of the COVID-19 virus, refurbishing firm Back Market is showing increased growth globally.

The Paris -based startup encourages customers to send in their old devices so they can be refurbished and resold into the e-commerce secondhand market. The growth achieved in the midst of the COVID-19 crisis is partly due to increased laptop sales as people seek better devices to work remotely.

For people who are unsure whether refurbished products are reliable, Back Market permits customers to send in old devices, exchange them for newer versions and pay the difference. CEO Thibaud Hug de Larauze said this payback service is currently possible only in France, but starting in Q2, it will be available in other markets.

Founded in 2014, Back Market has raised a total of €48 million in funding over two rounds, most recently a Series B in June 2018. The company is profitable and reportedly still has money to spend from its last funding round.

&We don&t release the gross merchandise volume, but ita three-digit growth rate,& Hug de Larauze told TechCrunch. &We saw an increase in demand for laptops, printers and other devices needed for working at home. Demand for refurbished phones is going down as people seek to get the first necessity items, like food for their situation.&

Over the past two weeks, Back Market saw skyrocketing demand from Italy, a nation with a high coronavirus death toll where citizens were warned they would be confined to their homes for four weeks.

Another factor that helped the platformgrowth: Smartphone brands like Apple and Samsung closed their retail stores, a move that turned Back Market into a major supply channel. While offline retailers and carriers are shut down in Europe, Hug de Larauze says Chinese offline retailers and refurbishing factories are starting to get back to work.

Looks like things haven&t gone completely smoothly with Quibi‘s launch.

The issue appears to have been resolved, but the Quibi customer support account tweeted this afternoon that &some users may be experiencing problems with the Quibi app,& only to add an hour later that &Users should once again be able to use the Quibi app normally. Thank you for your patience.&

Itnot clear how widespread the outage was, but according to The Verge, one staffer saw an error screen and was unable to browse the app, while another was unable to create an account. The app seems to be working normally as I write this shortly after 4pm Eastern.

If nothing else, ita reminder that reliably delivering streaming video is hard, even for a startup thatraised $1.75 billion. Heck, even Disney experienced widespread streaming issues when it launched Disney+ in November. (It all worked out fine.)

A quick catch-up for those of you still wondering what Quibi even is: Ita short-form video service founded by Hollywood executive Jeffrey Katzenberg and led by CEO Meg Whitman (previously CEO of Hewlett Packard Enterprise and eBay).

The app islaunching with nearly 50 shows today, all of them created specifically for mobile, with episodes that are less than 10 minutes long. After a 90-day free trial, it&ll cost you $4.99 with ads or $7.99 per month without ads.

TechCrunch confirmed today that BounceX (the firm is rebranding this year) has executed layoffs and salary cuts in the wake of recent COVID-19-led economic disruptions.

Many startups are undergoing staff cuts as the domestic and global economies slow, making individual reductions less newsworthy as the layoff tally rises. However, as BounceX is a company we&ve recently highlighted for its growth and capital efficiency, its own cuts are worth noting.

Reductions

TechCrunch was tipped concerning the BounceX staff cuts and salary reductions earlier today, events that the company confirmed this afternoon. Our original tipster pegged the cuts at around 20% of staff, with pay cuts for the rest of its denizens.

The company confirmed the existence of salary cuts and layoffs, but did not affirm our figures. HereBounceX on its hard day; the firm confirmed pay cuts via a spokesperson separately from this comment:

COVID-19 has hit our client base really hard, especially if they had significant retail presence. In order to accommodate clients and help stabilize our business - their businesses, we made the immensely difficult decision to move forward with a reduction in force. While we expected over 30% growth this year and adding 150 new roles by year end, we were forced to consolidate roles in order to do everything we could to take care of as many of our people as possible and continue to help our clients get through this.

It is not a surprise that BounceX was planning revenue growth and 150 new roles; the company recently crossed the $100 million ARR threshold, an event that TechCrunch covered as part of our long-running series focused on companies that reach the revenue threshold.

Indeed, in February, when BounceX shared the milestone, the firm also announced a rebrand, stating that it would change its name to Wunderkind. As you can read from the name, BounceX was feeling good at the time, looking to the future, proud of its growth and track record of efficient capital use.

As TechCrunch wrote at the time:

Wunderkind has been super efficient to date, with [CEO Ryan] Urban telling TechCrunch that &the amount of equity [his company has] actually put to work is probably sub-$35 million,& with less than $50 million in equity capital raised. The company also has debt lines that it can use, the CEO noted.

Given its history of conservative capital management, it doesn&t seem likely that BounceX is in existential danger after its layoffs. The companydebt line — though we don&t know anything about its covenants — could provide more cushion. But its quick turnaround in fortunes shows how fast things can change.

The impact of COVID-19 on BounceX shows that no company, no matter how successful they were in February, is safe in April. Heck, TripActions was crowing about a huge new debt facility it secured right before COVID-19; the firm has since pared staff as well.

Stocks rallied Monday, with all major indices snapping back into positive territories as investors seized on any positive developments in the fight to mitigate the spread of COVID-19, the disease caused by the coronavirus.

The stock market is, of course, not the economy. And this is likely a dead-cat bounce — a temporary recovery after a big fall. The question is how many dead-cat bounces will we see in the coming weeks?

And while the economic fallout from the COVID-19 pandemic is continuing, that didn&t stop investors from grasping at data from John Hopkins University that suggests the number of new COVID-19 cases is slowing. The institutioncoronavirus map, which has become a go-to source, showed 25,200 new cases rising on March 31, then rising to 33,300 new cases by April 3. Those numbers dropped to 28,200 new cases April 4, per its data; other trackers have posted slightly different results.

Todayrally will be tested in the days and weeks to come as COVID-19 cases continue and eventually hit a peak before plateauing. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and a member of the White House coronavirus task force, has warned that cases, and deaths, will likely surge in the next week.

Here are the dayresults:

• Dow Jones Industrial Average: up 7.59%, or 1,597.21 points, to close at 22.649.74
• S-P 500: rose 6.95%, or 172.86 points, to close at 2,661.51
• Nasdaq composite: popped 7.33%, or 540.15 points, to close at 7,913.24

There were other indirect COVID-19 fundamentals, such as new sales guidance or analyst notes that also moved certain stocks.

E-commerce stocks, including eBay and Amazon, saw positive movement. Online retailer Wayfair was perhaps the biggest mover in this category. The companyshares opened 36% higher after reporting its gross revenue growth rate more than doubled at the end of March. Wayfair shares closed up 41.7% to $71.50.

Music streaming company Spotify saw shares decline more than 4% after Raymond James downgraded the stock from &strong buy& to &market perform,& citing that COVID-19 was causing less engagement and fewer downloads as users spend more time indoors. Spotify shares did manage to bounce back during the day and ended closing up nearly 0.33%, to $122.52.

Shares of SaaS companies rallied on the day as well, with the Bessemer cloud index rising 6.79% on the day; shares of SaaS companies, modern software firms, have enjoyed strong revenue multiples in recent years. They have tracked the broader indices down, however, and remain in bear-market territory.

Looking ahead, we&re entering earnings season during a period of intense economic uncertainty; how the stock market performs in the future will at least partially depend on how companies performed in Q1 2020, and what they project for the future. Get ready.

A new COVID-19 vaccine candidate is entering Phase 1 clinical human testing today, after the U.S. Food and Drug Administration (FDA) accepted an application from Inovio Pharmaceuticals under the regulatorInvestigational New Drug program. Inovio plans to inject its first volunteer test subject with the INO-4800 DNA vaccine candidate it has developed, following promising results from preclinical studies performed on animals that did indicate increased immune response.

The Inovio DNA vaccine candidate works by injecting a specifically engineered plasmid (a small, independent genetic structure) into a patient so that their cells can produce a desired, targeted antibody to fight off a specific infection. DNA vaccines, while available and approved for a variety of animal infections in veterinary medicine, have not yet been approved for human use.

That said, Inoviowork isn&t starting from scratch: The company previously completed a Phase 1 study for a DNA vaccine candidate for Middle East Respiratory Syndrome (MERS), where it showed promising results and a high level of antibodies produced in subjects that persisted for an extended period of time.

Inovio has been able to scale up quickly, developing and producing &thousands of doses& of INO-4800 in just a few short weeks in order to support its Phase 1 and Phase 2 trials. The company has done so in part thanks to backing from the Bill and Melinda Gates Foundation, as well as funding from other nonprofits and organizations. If clinical trials are successful, Inovio says it will be able to have up to one million doses of the vaccine ready by the end of the year, for use both in additional trials and for potential emergency use pending authorization.

This is the second vaccine to undertake Phase 1 clinical testing on human subjects: Moderna began its trial in mid-March. Inoviotrial will be made up of 40 volunteers, all healthy adults selected via screening conducted at either PhiladelphiaPerelman School of Medicine at the University of Pennsylvania, or the Center for Pharmaceutical Research in Kansas City. It&ll span the next several weeks, and the company expects data around the immune responses from test subjects, as well as info pertaining to the safety of the treatment for humans, to be available by late this summer.

Any broad clearance or approval for use is still likely at least a year to 18 months away, but the pace with which human trials are beginning is still exceptional, so hopefully we won&t have to wait too much longer than that.